COMERICA INC (CMA)

US2003401070 - Common Stock

53.38  +0.31 (+0.58%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CMA. CMA was compared to 412 industry peers in the Banks industry. CMA has a bad profitability rating. Also its financial health evaluation is rather negative. CMA has a valuation in line with the averages, but on the other hand it scores bad on growth. CMA also has an excellent dividend rating.



3

1. Profitability

1.1 Basic Checks

CMA had positive earnings in the past year.
CMA had a positive operating cash flow in the past year.
CMA had positive earnings in each of the past 5 years.
In the past 5 years CMA always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of 0.84%, CMA perfoms like the industry average, outperforming 49.03% of the companies in the same industry.
CMA has a better Return On Equity (11.04%) than 69.90% of its industry peers.
Industry RankSector Rank
ROA 0.84%
ROE 11.04%
ROIC N/A
ROA(3y)1.17%
ROA(5y)1.14%
ROE(3y)16.47%
ROE(5y)14.34%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CMA has a worse Profit Margin (19.73%) than 67.96% of its industry peers.
CMA's Profit Margin has declined in the last couple of years.
CMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 19.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.83%
PM growth 5Y-8.4%
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

CMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CMA has been increased compared to 1 year ago.
The number of shares outstanding for CMA has been reduced compared to 5 years ago.
Compared to 1 year ago, CMA has an improved debt to assets ratio.

2.2 Solvency

The Debt to FCF ratio of CMA is 7.72, which is on the high side as it means it would take CMA, 7.72 years of fcf income to pay off all of its debts.
CMA has a worse Debt to FCF ratio (7.72) than 75.73% of its industry peers.
CMA has a Debt/Equity ratio of 0.53. This is a neutral value indicating CMA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.53, CMA is not doing good in the industry: 71.60% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.72
Altman-Z N/A
ROIC/WACCN/A
WACC13.33%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

2

3. Growth

3.1 Past

The earnings per share for CMA have decreased strongly by -30.45% in the last year.
The Earnings Per Share has been growing slightly by 1.13% on average over the past years.
The Revenue for CMA has decreased by -11.45% in the past year. This is quite bad
Measured over the past years, CMA shows a small growth in Revenue. The Revenue has been growing by 1.54% on average per year.
EPS 1Y (TTM)-30.45%
EPS 3Y33.04%
EPS 5Y1.13%
EPS growth Q2Q-46.03%
Revenue 1Y (TTM)-11.45%
Revenue growth 3Y7.25%
Revenue growth 5Y1.54%
Revenue growth Q2Q-20.81%

3.2 Future

Based on estimates for the next years, CMA will show a decrease in Earnings Per Share. The EPS will decrease by -3.90% on average per year.
Based on estimates for the next years, CMA will show a small growth in Revenue. The Revenue will grow by 0.32% on average per year.
EPS Next Y-31.6%
EPS Next 2Y-10.81%
EPS Next 3Y-3.4%
EPS Next 5Y-3.9%
Revenue Next Year-8.07%
Revenue Next 2Y-1.01%
Revenue Next 3Y0.74%
Revenue Next 5Y0.32%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.09, the valuation of CMA can be described as very reasonable.
74.27% of the companies in the same industry are more expensive than CMA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.73. CMA is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 8.71 indicates a reasonable valuation of CMA.
Based on the Price/Forward Earnings ratio, CMA is valued a bit cheaper than the industry average as 76.21% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.41, CMA is valued rather cheaply.
Industry RankSector Rank
PE 8.09
Fwd PE 8.71

4.2 Price Multiples

CMA's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CMA is more expensive than 76.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.18
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as CMA's earnings are expected to decrease with -3.40% in the coming years.
PEG (NY)N/A
PEG (5Y)7.17
EPS Next 2Y-10.81%
EPS Next 3Y-3.4%

8

5. Dividend

5.1 Amount

CMA has a Yearly Dividend Yield of 5.48%, which is a nice return.
CMA's Dividend Yield is rather good when compared to the industry average which is at 3.76. CMA pays more dividend than 87.38% of the companies in the same industry.
CMA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 5.48%

5.2 History

On average, the dividend of CMA grows each year by 13.67%, which is quite nice.
CMA has paid a dividend for at least 10 years, which is a reliable track record.
CMA has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.67%
Div Incr Years1
Div Non Decr Years14

5.3 Sustainability

CMA pays out 59.58% of its income as dividend. This is a bit on the high side, but may be sustainable.
CMA's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP59.58%
EPS Next 2Y-10.81%
EPS Next 3Y-3.4%

COMERICA INC

NYSE:CMA (5/6/2024, 11:47:09 AM)

53.38

+0.31 (+0.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.08B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 5.48%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.09
Fwd PE 8.71
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)7.17
Profitability
Industry RankSector Rank
ROA 0.84%
ROE 11.04%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 19.73%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-30.45%
EPS 3Y33.04%
EPS 5Y
EPS growth Q2Q
EPS Next Y-31.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.45%
Revenue growth 3Y7.25%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y